US Bancorp’s Cano Health, Inc. CANO Stock Holding History

US Bancorp’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-86	Closed	-$2.19K	–	4217
2023 Q3	$2.19K	Hold	86	–	–	﹤0.01%	3639
2023 Q2	$12K	Buy	86 +61	+244%	+$7.83K	﹤0.01%	3198
2023 Q1	$2.28K	Sell	25 -18	-42%	-$2.44K	﹤0.01%	3727
2022 Q4	$5.87K	Buy	+43	New	+$14.6K	﹤0.01%	3463

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Bancorp's CANO Position: Q4 2023 in Review

US Bancorp sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 86 shares — an estimated $2.19K sold.

US Bancorp first reported a position in CANO in Q4 2022 and held it in 4 quarters. The position peaked at $12K in Q2 2023. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

US Bancorp reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
US Bancorp sold 86 Cano Health, Inc. shares in Q4 2023, an estimated $2.19K.
US Bancorp first reported a position in Cano Health, Inc. in Q4 2022 and held it in 4 quarters.
US Bancorp's Cano Health, Inc. position peaked at $12K in Q2 2023.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on US Bancorp's 13F filing for Q4 2023, filed 9 Feb 2024.